Name | FGI-106 |
---|---|
Synonyms |
FGI-106
BRT994456W N,N'-Bis[3-(dimethylamino)propyl]-3,9-dimethylquinolino[8,7-h]quinoline-1,7-diamine Quino[8,7-h]quinoline-1,7-diamine, N1,N7-bis[3-(dimethylamino)propyl]-3,9-dimethyl- FGI-106 FREE BASE |
Description | FGI-106 is a broad-spectrum inhibitor of multiple blood-borne viruses (HCV, HBV, HIV) as well as emerging biothreats (Ebola, VEE, Cowpox, PRRSV infection) with EC50 of 0.2-10 uM; inhibits the interaction of TSG101 with its cognate viral ligands; displays an ability to prevent lethality from Ebola in vivo; well-tolerated and orally bioavailable. |
---|---|
References | References 1. Kinch MS, et al. Am J Transl Res. 2009 Jan 5;1(1):87-98. 2. De Clercq E. Med Res Rev. 2013 Nov;33(6):1249-77. View Related Products by Target Filovirus |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 659.9±55.0 °C at 760 mmHg |
Molecular Formula | C28H38N6 |
Molecular Weight | 458.642 |
Flash Point | 352.9±31.5 °C |
Exact Mass | 458.315796 |
LogP | 5.17 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.678 |